LM
Therapeutic Areas
Biovica Pipeline
| Drug | Indication | Phase |
|---|---|---|
| DiviTum® TKa | Monitoring metastatic breast cancer (on CDK4/6 inhibitors) | Commercial |
Leadership Team at Biovica
FA
Fredrik Alpsten
Chairman of the Board
AR
Anders Rylander
Chief Executive Officer (CEO) & Board Member
NB
Niels Bogerd
Board Member
AB
Annika Berg (Annika Carlsson Berg)
Board Member
JS
Jesper Söderqvist
Board Member
MH
Maria Holmlund
Board Member
MF
Marie-Louise Fjällskog
Board Member
AM
Anders Morén
Chief Financial Officer (CFO)
HR
Hanna Ritzén
Senior Vice President, Global Marketing and Business Development
HW
Henrik Winther
Senior Vice President, Business Development